Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Viracta Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Viracta Therapeutics Inc market cap is $388,700.00.
What is the 52-week high for Viracta Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Viracta Therapeutics Inc 52 week high is $0.58 as of September 09, 2025.
What is the 52-week low for Viracta Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Viracta Therapeutics Inc 52 week low is $0.008 as of September 09, 2025.
What is Viracta Therapeutics Inc stock price today?
Viracta Therapeutics Inc stock price today is $0.0098.
What was Viracta Therapeutics Inc stock price yesterday?
Viracta Therapeutics Inc stock price yesterday was $0.0096.
What is the PE ratio of Viracta Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Viracta Therapeutics Inc’s P/E ratio is -0.01.
What is the Price-to-Book ratio of Viracta Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Viracta Therapeutics Inc P/B ratio is -0.0587.
What is the 50-day moving average of Viracta Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Viracta Therapeutics Inc 50-day moving average is $0.0163.